Jade Biosciences Net Debt Growth & History (JBIO)

Jade Biosciences's net debt was −$87.6M for fiscal 2025.

View full Jade Biosciences company overview

Jade Biosciences annual net debt history

Jade Biosciences annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$87.6M−$18.6M
20242024-12-31−$69.0M−$46.2M
20232023-12-31−$22.8M−$1.5M
20222022-12-31−$21.3M$32.3M
20212021-12-31−$53.6M

Jade Biosciences net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Jade Biosciences's net debt decreased from −$53.6M to −$87.6M, a change of −$34.0M. The latest reported quarter, Q2 2026, shows −$106.5M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Jade Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about JBIO yet. Start the conversation.

Write the first post